Personalized treatments according to type of obesity

January 26, 2006

The Danone Institute has provided a fellowship for basic research to Ana Antón Solanas, a research assistant in the Dietetics and Diet Therapy Unit of the University of Navarra. With the help of this fellowship, the researcher will collaborate in a program for defining individualized treatments for each type of obesity.

The grant will finance her participation in the project entitled "Effects of a Hypocaloric Diet and Physical Training in the Metabolic and Hormonal Response in a Group of Obese Women with a Gln27Glu Polymorphism in the Beta2adrenergic Receptor."

The objective of the study consists in detecting the metabolic and hormonal response of overweight women with Gln27Glu polymorphism. That patients with this genetic trait presented a greater index of body mass than normal women, despite performing exercise on a regular basis. Our goal consists precisely in understanding the reason that women with this trait are more resistant to weight loss.

The ultimate objective of the project of which Ms. Antón forms part is to understand the characteristics of obese persons with differing genetic polymorphisms, and to develop individualized treatments for each case. Until now, in the treatment of obesity, clinical practice focused on the likes and dislikes of the patients. In the future, however, we will be able to create diets and exercise regimens which are genetically adjusted to the individual person.

Subtract 500 calories daily and perform physical exercise

The 37 patients which will participate in the study will be required to follow a hypocaloric diet for 16 weeks, with a reduction of 500 calories with respect to their daily energy expenditure, and a controlled program of physical exercise.
-end-


Elhuyar Fundazioa

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/lookup/doi/10.1503/cmaj.191707.

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.